FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E
Tuberculosis HIV/AIDS

Incidence of Tuberculosis in HIV-infected Indian adults

27 Jun 2020

The prevalence of antiretroviral therapy (ART) has considerably reduced the occurrence of TB in People Living with HIV (PLHIV). However, since TB is a highly infectious disease, the incidence of TB amongst PLHIV remains high. India has the third-highest HIV burden and almost 1 million annual TB incidence amongst PLHIV. This article documents a retrospective cohort study using programmatic data from one of India’s largest public-sector ART delivery programs in Pune, Maharashtra. It aims to estimate the incidence rate and risk factors of TB among HIV-infected adults who receive first- and second-line ART. This paper is relevant for government health departments and health officials involved in PLHIV TB care and management.

Download PDF
PUBLISHED BY
BMC Infectious Diseases
YEAR OF PUBLISHING
2019
AUTHORS
Akshay N. Gupte, et al.

Categories

For implementers Research

RELATED
CONTENT

For implementers Research

Pediatric HIV in India: Current Scenario and the Future

Reducing the risk of HIV in newborns and treating children born with HIV.

by Anita Nath 30 min read

HIV/AIDS
For implementers

Task Shifting of HIV Screening in Marginalized Communities

Empowering community members to conduct HIV screenings could help reach the unre...

by Catherine Cove 5 min read

HIV/AIDS
KEY ORGANIZATIONS

FOLLOW US

Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2022 Swasti Health Catalyst